What We're Reading: Page 11
Industry reads hand-picked by our editors
Jul 11, 2025
-
Bloomberg
FDA Offers to Trade Faster Drug Reviews for Lower US Prices
-
PharmaVoice
Pricing watchdog will take on the rising cost of drugs at launch
-
The New York Times
A 37,000-Year Chronicle of What Once Ailed Us
Jul 10, 2025
Jul 09, 2025
-
Fierce Biotec
Biopharma layoffs for first half of the year jump 32% YOY
-
BioSpace
Supreme Court Suspends Injunction Preventing RFK Jr.’s HHS Cuts
-
The Wall Street Journal
The MAHA Movement Loves Psychedelics. Should Wall Street?
Jul 08, 2025
-
The New York Times Magazine
Inside the collapse of the F.D.A.
-
C&EN
Molecular glue degraders are more versatile than previously thought
-
FirstWord Pharma
Taiho’s investigational DMD therapy flunks late-stage study
Jul 07, 2025
Jul 02, 2025
Jul 01, 2025
-
The Times
AstraZeneca CEO wants to move listing to the US
-
MIT Technology Review
Meet Jim O’Neill, the longevity enthusiast who is now RFK Jr.’s right-hand man
-
Reuters
How Novo Nordisk misread the US market for its weight loss sensation
-
FirstWord Pharma
FDA mandates label updates for ADHD stimulants over weight loss risk in young children
Previous
